Learn more about HPV vaccination.

HPV vaccines are among the most effective vaccines available to date, learn more about how we are working with the global community to expand access to these vaccines. 

Call for abstracts

HPV Vaccination Programs: From Pre-introduction Planning to Restoration and Sustainability

24 – 25 Sept 2022 | Addis Ababa, Ethiopia

2022 Symposium Objectives

Abstracts due August 2, 2022

23:59 Central European Summer Time

The Full Picture

Cervical cancer is the 4th most common cancer among women.

In 2018, an estimated 570,000 women worldwide were diagnosed with cervical cancer and about 311,000 died from cervical cancer. 85% of the burden falling on women from lower-middle income countries. Human papillomavirus is linked to 99% of all cervical cancer cases.

The Vaccine

The HPV vaccine prevents over 90% of HPV-related cancers,

along with other prevention practices.

The Community

CHIC aims to increase access to the HPV vaccine

by strengthening the HPV immunization community.

The Mission

CHIC’s mission is to effectively translate implementation research findings

to guide practice and more equitable access to immunization within the context on an increasingly stable HPV vaccine market.


Featured Resources

CHIC HPV Council Consensus Statement on One-Dose Recommendation

by CHIC HPV Council

The HPV Council of the Coalition to Strengthen the HPV Immunization Community (CHIC) welcomes new global recommendations on single-dose options for human papilloma virus (HPV) vaccination.

Briefing on HPV and Vaccination

This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on LMICs and the significant barriers in the implementation of vaccination programs.

title slide

Human Papillomavirus – The Current Landscape of HPV Vaccines Globally and the CHIC Project

The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines, and the goals of the CHIC project.